BusinessCofactor Genomics announces new collaboration with the National Cancer Institute (NCI) to demonstrate power of RNA-based immune profiling assayBy Nasdaq OMXMar 20, 2018, 12:31 PM UTC
BusinessCofactor Genomics Launches Paragon, a Comprehensive Quantitative Solid Tumor Immune Profiling AssayBy Nasdaq OMXFeb 8, 2018, 1:00 PM UTC
